Dashboard
Manage Tickers

INO INOVIO PHARMACEUTICALS, INC.


$ 1.77 $ 0.02 (1.14 %)    

Friday, 21-Nov-2025 10:01:16 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 1.73
$ 1.75 x 3,200
$ 1.77 x 2,500
$ 1.73 - $ 1.78
$ 1.30 - $ 4.61
831,280
na
92.68M
$ 1.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

piper-sandler-reiterates-overweight-on-inovio-pharmaceuticals-raises-price-target-to-6
Piper Sandler Reiterates Overweight on Ino...
11/14/2025 16:06:24

Piper Sandler analyst Edward Tenthoff reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight and raises the price ...

inovio-pharma-prices-public-offering-of-13158m-common-shares-at-190shr
INOVIO Pharma Prices Public Offering Of 13...
11/11/2025 13:43:02

INOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to h...

inovio-prices-3158000-share-public-offering-at-190share
INOVIO Prices 3,158,000 Share Public Offer...
11/11/2025 13:41:49

update-inovio-pharmaceuticals-q3-adj-eps-044-misses-042-estimate
UPDATE: Inovio Pharmaceuticals Q3 Adj. EPS...
11/10/2025 23:44:05

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate ...

inovio-announces-proposed-public-offering-of-common-stock-no-size-or-amount-disclosed
INOVIO Announces Proposed Public Offering ...
11/10/2025 23:14:11

NOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to he...

earnings-scheduled-for-november-10-2025
Earnings Scheduled For November 10, 2025
11/10/2025 11:12:02

inovio-completes-rolling-bla-submission-for-ino-3107-in-treatment-of-rrp-in-adults
INOVIO Completes Rolling BLA Submission Fo...
11/03/2025 13:17:36

inovio-announces-publication-of-results-from-phase-1-proof-of-concept-trial-evaluating-dmabs-for-covid-19
INOVIO Announces Publication Of Results Fr...
10/21/2025 12:09:13

inovio-on-track-to-complete-ino-3107-biologics-license-application-by-2h25-targets-fda-acceptance-by-year-end
INOVIO On Track To Complete INO-3107 Biolo...
08/26/2025 12:09:51

Complete submission of the Biologics License Application (BLA) remains on track for 2H25 with the goal of file acceptance by U....

hc-wainwright--co-reiterates-neutral-on-inovio-pharmaceuticals-maintains-3-price-target
HC Wainwright & Co. Reiterates Neutral on ...
08/14/2025 11:29:58

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Neutral and maintai...

inovio-pharmaceuticals-q2-eps-061-beats-062-estimate
Inovio Pharmaceuticals Q2 EPS $(0.61) Beat...
08/12/2025 20:05:56

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

earnings-outlook-for-inovio-pharmaceuticals
Earnings Outlook For Inovio Pharmaceuticals
08/11/2025 18:02:16

inovios-announces-peer-reviewed-data-from-a-retrospective-study-investigating-the-long-term-clinical-and-safety-response-of-patients-treated-with-ino-3107-were-published-online-in-the-laryngoscope-ino-3107-shows-sustained-improvement-in-rrp-patients-cutting-surgeries-by-over-75-in-year-2
INOVIO's Announces Peer-reviewed Data From...
08/11/2025 12:09:36

Retrospective trial showed Overall Response Rate (ORR) improved to 86% at the end of the second 12-month period (Year 2) compar...

this-wingstop-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Wingstop Analyst Begins Coverage On A...
07/09/2025 14:13:46

piper-sandler-initiates-coverage-on-inovio-pharmaceuticals-with-overweight-rating-announces-price-target-of-5
Piper Sandler Initiates Coverage On Inovio...
07/09/2025 12:24:59

Piper Sandler initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight rating and announces Price Target o...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/03/2025 21:05:44

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/03/2025 17:07:08

crude-oil-down-1-tripadvisor-shares-jump
Crude Oil Down 1%; Tripadvisor Shares Jump
07/03/2025 16:31:55

dow-jumps-over-200-points-us-nonfarm-payrolls-beat-estimates
Dow Jumps Over 200 Points; US Nonfarm Payr...
07/03/2025 14:08:15

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION